Why is Alivus Life falling/rising?

As of 18-Aug, Alivus Life Sciences Ltd is experiencing a price increase, currently at 960.00, reflecting a rise of 18.6 or 1.98%. Today's performance indicates that the stock has outperformed its sector by 1.75%, reaching an intraday high of Rs 961.7. However, despite this positive movement, the stock has shown a decline of 9.11% over the past month and a year-to-date decrease of 2.93%. The company benefits from high management efficiency, evidenced by a return on equity (ROE) of 25.32% and a low debt-to-equity ratio, but it faces challenges with poor long-term growth, as net sales and operating profit have only grown at annual rates of 4.49% and 2.26%, respectively, over the last five years.
Broader market context shows that while Alivus Life has outperformed the Sensex by 3.07% over the past week, it has underperformed over the longer term, with a year-on-year return of -1.50% compared to the Sensex's 1.04% gain. The stock's liquidity appears adequate for trading, but a significant drop in delivery volume suggests declining investor participation, which could impact future price movements. Overall, while the stock is currently rising, its long-term growth prospects remain a concern, which may influence investor sentiment moving forward.